Blocking adenosine A 2A receptor reduces peritoneal fibrosis in two independent experimental models

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2392-2399

  Nakav, Sigal ^a   Kachko, Leonid ^a   Vorobiov, Marina ^a   Rogachev, Boris ^a   Chaimovitz, Cidio ^a   Zlotnik, Moshe ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

A 2A receptor; Adenosine; Caffeine; Peritoneal fibroblasts; Peritoneal fibrosis

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A2A RECEPTOR; CAFFEINE; CALVASCULIN; CHLORHEXIDINE GLUCONATE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; PERITONEAL DIALYSIS FLUID; CENTRAL STIMULANT AGENT; CHLORHEXIDINE; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WILD TYPE; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG ANTAGONISM; DRUG POTENTIATION; FIBROSIS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERITONEAL CAVITY;

ADENOSINE; ANIMALS; CAFFEINE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; CHLORHEXIDINE; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; MICE; MICE, KNOCKOUT; PERITONEAL CAVITY; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; VASODILATOR AGENTS;

EID: 67651091644     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp041     Document Type: Article

References (35)

1. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
2. Aguilera A, Yanez-Mo M, Selgas R et al. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Invest Drugs 2005; 6: 262-268
3. Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif 1989; 7: 74-85
4. Honda K, Nitta K, Horita S et al. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-176
5. Lu M, Kuroki M, Amano S et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101: 1219-1224
6. Alscher DM, Biegger D, Mettang T et al. Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids. Artif Organs 2003; 27: 1035-1040
7. Witowski J, Korybalska K, Wisniewska J et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11: 729-739
8. Kolb M, Margetts PJ, Anthony DC et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001; 107: 1529-1536
9. Rogachev B, Ziv NY, Mazar J et al. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. Kidney Int 2006; 70: 675-681
10. Nakav S, Chaimovitz C, Sufaro Y et al. Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PLoS ONE 2008; 3: e2107
11. Mazar J, Rogachev B, Shaked G et al. Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology 2005; 102: 1174-1181
12. Montesinos MC, Desai A, Chen JF et al. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002; 160: 2009-2018
13. Chan ES, Montesinos MC, Fernandez P et al. AdenosineA(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol 2006; 148: 1144-1155
14. Chan ES, Fernandez P, Merchant AA et al. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum 2006; 54: 2632-2642
15. Olah ME, Ren H, Stiles GL. Adenosine receptors: protein and gene structure. Arch Int Pharmacodyn Ther 1995; 329: 135-150
16. Sitkovsky MV, Lukashev D, Apasov S et al. Physiological control of immune response and inflammatory tissue damage by hypoxiainducible factors and adenosine A2A receptors. Annu Rev Immunol 2004; 22: 657-682
17. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-39
18. Sitkovsky MV. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003; 65: 493-501
19. Ishii Y, Sawada T, Shimizu A et al. An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 2001; 16: 1262-1266
20. Ledent C, Vaugeois JM, Schiffmann SN et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997; 388: 674-678
21. Lawson WE, Polosukhin VV, Zoia O et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171: 899-907
22. Einbinder T, Sufaro Y, Yusim I et al. Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells. Kidney Int 2003; 63: 2103-2112
23. Stylianou E, Jenner LA, Davies M et al. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570
24. Man L, Lewis E, Einbinder T et al. Major involvement of CD40 in the regulation of chemokine secretion from human peritoneal mesothelial cells. Kidney Int 2003; 64: 2064-2071
25. Fredholm BB, Battig K, Holmen J et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51: 83-133
26. Allen-Gipson DS, Wong J, Spurzem JR et al. Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L849-L855
27. Chunn JL, Molina JG, Mi T et al. Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficientmice. J Immunol 2005; 175: 1937-1946
28. Blackburn MR, Lee CG, Young HW et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 2003; 112: 332-344
29. Saxena R, West C. Peritoneal dialysis: a primary care perspective. J Am Board Fam Med 2006; 19: 380-389
30. Faull RJ. Bad and good growth factors in the peritoneal cavity. Nephrology (Carlton) 2005; 10: 234-239
31. Gressner OA, Lahme B, Rehbein K et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008
32. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005; 129: 1928-1936
33. Takagi H, King GL, Robinson GS et al. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 1996; 37: 2165-2176
34. Fischer S, Sharma HS, Karliczek GF et al. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Res Mol Brain Res 1995; 28: 141-148
35. Ethier MF, Chander V, Dobson JG, Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 1993; 265: H131-H138